Serveur d'exploration Santé et pratique musicale

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.

Identifieur interne : 000847 ( Main/Exploration ); précédent : 000846; suivant : 000848

Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.

Auteurs : Jodie Grigg [Australie] ; Monica J. Barratt [Australie] ; Simon Lenton [Australie]

Source :

RBID : pubmed:30392182

Descripteurs français

English descriptors

Abstract

INTRODUCTION AND AIMS

The term 'double dropping' refers to a person consuming two drugs simultaneously, typically two ecstasy pills. This practice has been reported in numerous countries, including Australia; however, the prevalence and correlates of double dropping among ecstasy users is unknown. Double dropping is particularly risky when adulteration of 'ecstasy' with novel substances and higher dosages of MDMA in pure ecstasy pills have both been increasingly reported. This paper investigates the prevalence and correlates of double dropping in a purposive sample of Australian festival-goers who used ecstasy at the last festival they attended.

DESIGN AND METHODS

A web survey was completed by almost 2000 Australian festival-goers. The analytic sample (n = 777) was 59% male and had a median age of 20 years (interquartile range 19-23).

RESULTS

Almost half (48%) of respondents who used ecstasy pills reported double dropping in association with the last festival attended. Multivariable logistic regression found respondents who were younger, male, more frequent ecstasy users, more frequent festival-goers, had a preference for electronic dance music, attended a multi-day festival and used ecstasy in pill form were at greater odds of reporting double dropping at the last festival attended.

DISCUSSION AND CONCLUSIONS

Double dropping was a commonly reported practice among festival-goers in this purposive sample. While this practice may reflect historically low-dose ecstasy pills in Australia, the changing contexts of novel drugs and increasing MDMA purity may warrant consideration of harm-reduction interventions and drug-checking services which could help festival-goers make more informed decisions about drug dosage.


DOI: 10.1111/dar.12843
PubMed: 30392182


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.</title>
<author>
<name sortKey="Grigg, Jodie" sort="Grigg, Jodie" uniqKey="Grigg J" first="Jodie" last="Grigg">Jodie Grigg</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Drug Research Institute, Curtin University, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barratt, Monica J" sort="Barratt, Monica J" uniqKey="Barratt M" first="Monica J" last="Barratt">Monica J. Barratt</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Drug Research Institute, Curtin University, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Australia, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Behaviours and Health Risks Program, Burnet Institute, Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Behaviours and Health Risks Program, Burnet Institute, Melbourne</wicri:regionArea>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lenton, Simon" sort="Lenton, Simon" uniqKey="Lenton S" first="Simon" last="Lenton">Simon Lenton</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Drug Research Institute, Curtin University, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30392182</idno>
<idno type="pmid">30392182</idno>
<idno type="doi">10.1111/dar.12843</idno>
<idno type="wicri:Area/Main/Corpus">000662</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000662</idno>
<idno type="wicri:Area/Main/Curation">000662</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000662</idno>
<idno type="wicri:Area/Main/Exploration">000662</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.</title>
<author>
<name sortKey="Grigg, Jodie" sort="Grigg, Jodie" uniqKey="Grigg J" first="Jodie" last="Grigg">Jodie Grigg</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Drug Research Institute, Curtin University, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Barratt, Monica J" sort="Barratt, Monica J" uniqKey="Barratt M" first="Monica J" last="Barratt">Monica J. Barratt</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Drug Research Institute, Curtin University, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Australia, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Behaviours and Health Risks Program, Burnet Institute, Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Behaviours and Health Risks Program, Burnet Institute, Melbourne</wicri:regionArea>
<placeName>
<settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lenton, Simon" sort="Lenton, Simon" uniqKey="Lenton S" first="Simon" last="Lenton">Simon Lenton</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Drug Research Institute, Curtin University, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Drug and alcohol review</title>
<idno type="eISSN">1465-3362</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Australia (epidemiology)</term>
<term>Dose-Response Relationship, Drug (MeSH)</term>
<term>Female (MeSH)</term>
<term>Holidays (psychology)</term>
<term>Humans (MeSH)</term>
<term>Illicit Drugs (adverse effects)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Music (psychology)</term>
<term>N-Methyl-3,4-methylenedioxyamphetamine (administration & dosage)</term>
<term>N-Methyl-3,4-methylenedioxyamphetamine (adverse effects)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Australie (épidémiologie)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Musique (psychologie)</term>
<term>Mâle (MeSH)</term>
<term>N-Méthyl-3,4-méthylènedioxy-amphétamine (administration et posologie)</term>
<term>N-Méthyl-3,4-méthylènedioxy-amphétamine (effets indésirables)</term>
<term>Relation dose-effet des médicaments (MeSH)</term>
<term>Vacances (psychologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>N-Methyl-3,4-methylenedioxyamphetamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Illicit Drugs</term>
<term>N-Methyl-3,4-methylenedioxyamphetamine</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Australia</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>N-Méthyl-3,4-méthylènedioxy-amphétamine</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>N-Méthyl-3,4-méthylènedioxy-amphétamine</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Musique</term>
<term>Vacances</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Holidays</term>
<term>Music</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Australie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Dose-Response Relationship, Drug</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Surveys and Questionnaires</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Relation dose-effet des médicaments</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Australie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>INTRODUCTION AND AIMS</b>
</p>
<p>The term 'double dropping' refers to a person consuming two drugs simultaneously, typically two ecstasy pills. This practice has been reported in numerous countries, including Australia; however, the prevalence and correlates of double dropping among ecstasy users is unknown. Double dropping is particularly risky when adulteration of 'ecstasy' with novel substances and higher dosages of MDMA in pure ecstasy pills have both been increasingly reported. This paper investigates the prevalence and correlates of double dropping in a purposive sample of Australian festival-goers who used ecstasy at the last festival they attended.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>DESIGN AND METHODS</b>
</p>
<p>A web survey was completed by almost 2000 Australian festival-goers. The analytic sample (n = 777) was 59% male and had a median age of 20 years (interquartile range 19-23).</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Almost half (48%) of respondents who used ecstasy pills reported double dropping in association with the last festival attended. Multivariable logistic regression found respondents who were younger, male, more frequent ecstasy users, more frequent festival-goers, had a preference for electronic dance music, attended a multi-day festival and used ecstasy in pill form were at greater odds of reporting double dropping at the last festival attended.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>DISCUSSION AND CONCLUSIONS</b>
</p>
<p>Double dropping was a commonly reported practice among festival-goers in this purposive sample. While this practice may reflect historically low-dose ecstasy pills in Australia, the changing contexts of novel drugs and increasing MDMA purity may warrant consideration of harm-reduction interventions and drug-checking services which could help festival-goers make more informed decisions about drug dosage.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30392182</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>02</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1465-3362</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>37</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2018</Year>
<Month>11</Month>
</PubDate>
</JournalIssue>
<Title>Drug and alcohol review</Title>
<ISOAbbreviation>Drug Alcohol Rev</ISOAbbreviation>
</Journal>
<ArticleTitle>Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.</ArticleTitle>
<Pagination>
<MedlinePgn>851-855</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/dar.12843</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION AND AIMS">The term 'double dropping' refers to a person consuming two drugs simultaneously, typically two ecstasy pills. This practice has been reported in numerous countries, including Australia; however, the prevalence and correlates of double dropping among ecstasy users is unknown. Double dropping is particularly risky when adulteration of 'ecstasy' with novel substances and higher dosages of MDMA in pure ecstasy pills have both been increasingly reported. This paper investigates the prevalence and correlates of double dropping in a purposive sample of Australian festival-goers who used ecstasy at the last festival they attended.</AbstractText>
<AbstractText Label="DESIGN AND METHODS">A web survey was completed by almost 2000 Australian festival-goers. The analytic sample (n = 777) was 59% male and had a median age of 20 years (interquartile range 19-23).</AbstractText>
<AbstractText Label="RESULTS">Almost half (48%) of respondents who used ecstasy pills reported double dropping in association with the last festival attended. Multivariable logistic regression found respondents who were younger, male, more frequent ecstasy users, more frequent festival-goers, had a preference for electronic dance music, attended a multi-day festival and used ecstasy in pill form were at greater odds of reporting double dropping at the last festival attended.</AbstractText>
<AbstractText Label="DISCUSSION AND CONCLUSIONS">Double dropping was a commonly reported practice among festival-goers in this purposive sample. While this practice may reflect historically low-dose ecstasy pills in Australia, the changing contexts of novel drugs and increasing MDMA purity may warrant consideration of harm-reduction interventions and drug-checking services which could help festival-goers make more informed decisions about drug dosage.</AbstractText>
<CopyrightInformation>© 2018 Australasian Professional Society on Alcohol and other Drugs.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Grigg</LastName>
<ForeName>Jodie</ForeName>
<Initials>J</Initials>
<Identifier Source="ORCID">0000-0002-0095-9794</Identifier>
<AffiliationInfo>
<Affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barratt</LastName>
<ForeName>Monica J</ForeName>
<Initials>MJ</Initials>
<Identifier Source="ORCID">0000-0002-1015-9379</Identifier>
<AffiliationInfo>
<Affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Behaviours and Health Risks Program, Burnet Institute, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lenton</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-7013-9812</Identifier>
<AffiliationInfo>
<Affiliation>National Drug Research Institute, Curtin University, Perth, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Australian Government under the Drug and Alcohol Program Fund</Agency>
<Country>International</Country>
</Grant>
<Grant>
<GrantID>APP1070140</GrantID>
<Agency>National Health and Medical Research Council</Agency>
<Country>International</Country>
</Grant>
<Grant>
<Agency>Australian Government Department of Health</Agency>
<Country>International</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>07</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Australia</Country>
<MedlineTA>Drug Alcohol Rev</MedlineTA>
<NlmUniqueID>9015440</NlmUniqueID>
<ISSNLinking>0959-5236</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013287">Illicit Drugs</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>KE1SEN21RM</RegistryNumber>
<NameOfSubstance UI="D018817">N-Methyl-3,4-methylenedioxyamphetamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006693" MajorTopicYN="N">Holidays</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013287" MajorTopicYN="Y">Illicit Drugs</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009146" MajorTopicYN="N">Music</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018817" MajorTopicYN="N">N-Methyl-3,4-methylenedioxyamphetamine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">double dropping</Keyword>
<Keyword MajorTopicYN="Y">drug users</Keyword>
<Keyword MajorTopicYN="Y">ecstasy</Keyword>
<Keyword MajorTopicYN="Y">harm reduction</Keyword>
<Keyword MajorTopicYN="Y">music festivals</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>07</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2018</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>06</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>11</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>2</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30392182</ArticleId>
<ArticleId IdType="doi">10.1111/dar.12843</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
<region>
<li>Nouvelle-Galles du Sud</li>
<li>Victoria (État)</li>
</region>
<settlement>
<li>Melbourne</li>
<li>Sydney</li>
</settlement>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Grigg, Jodie" sort="Grigg, Jodie" uniqKey="Grigg J" first="Jodie" last="Grigg">Jodie Grigg</name>
</noRegion>
<name sortKey="Barratt, Monica J" sort="Barratt, Monica J" uniqKey="Barratt M" first="Monica J" last="Barratt">Monica J. Barratt</name>
<name sortKey="Barratt, Monica J" sort="Barratt, Monica J" uniqKey="Barratt M" first="Monica J" last="Barratt">Monica J. Barratt</name>
<name sortKey="Barratt, Monica J" sort="Barratt, Monica J" uniqKey="Barratt M" first="Monica J" last="Barratt">Monica J. Barratt</name>
<name sortKey="Lenton, Simon" sort="Lenton, Simon" uniqKey="Lenton S" first="Simon" last="Lenton">Simon Lenton</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SanteMusiqueV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000847 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000847 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SanteMusiqueV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30392182
   |texte=   Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30392182" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SanteMusiqueV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Mon Mar 8 15:23:44 2021. Site generation: Mon Mar 8 15:23:58 2021